The global demand for Extracorporeal Circuit Cannulae Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028. Whereas with regards to volume, the market was calculated XX Kilo Units in 2021 and foreseen to touch XX Kilo Units by 2028 with a CAGR of XX% during 2022-2028.
Extracorporeal circuit cannulae are designed to provide life support (ECLS) during an extracorporeal technique of providing prolonged cardiac and respiratory support to patients whose lungs and heart are unable to provide an adequate gas exchange or perfusion to sustain life. These cannulae are mostly preferred during cardiopulmonary bypass, which provides shorter-term support with arrested native circulation. It is likewise used to help patients with the intense viral pneumonia-related with COVID-19 in situations where artificial ventilation isn't adequate to support blood oxygenation levels.
Market Dynamics
Global extracorporeal circuit cannulae market growth is influenced by factors such as growing cardiovascular and respiratory diseases, rising ECMO adoption as a bridge to lung transplantation, and the growing number of ECMO centers, conferences & training programs to increase awareness. Furthermore, the rising geriatric population and the number of people suffering from diseases in populous countries are factors that are predicted to offer significant growth opportunities for the extracorporeal circuit cannulae market. Currently, the market is experiencing an exciting period of all time due to the COVID-19 outbreak. Extracorporeal circuit cannulae is widely used for COVID-19 patients to support oxygen levels. However, complications associated with extracorporeal circuit cannulae, such as bleeding, infections, and other technical failures, along with the high cost is hindering the growth of the market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of extracorporeal circuit cannulae.
Market Segmentation
The entire extracorporeal circuit cannulae market has been sub-categorized into product and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product
- Arterial Cannulae
- Venous Cannulae
By Application
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for extracorporeal circuit cannulae market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Extracorporeal Circuit Cannulae Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the extracorporeal circuit cannulae market include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin Medical, Chalice Medical, Xenios AG. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.